The inflammatory response in myocardial injury, repair, and remodelling.
TLDR
Biomarker-based approaches are needed to identify patients with distinct pathophysiologic responses and to rationally implement inflammation-modulating strategies in patients with myocardial infarction.Abstract:
Myocardial infarction triggers an intense inflammatory response that is essential for cardiac repair, but which is also implicated in the pathogenesis of postinfarction remodelling and heart failure. Signals in the infarcted myocardium activate toll-like receptor signalling, while complement activation and generation of reactive oxygen species induce cytokine and chemokine upregulation. Leukocytes recruited to the infarcted area, remove dead cells and matrix debris by phagocytosis, while preparing the area for scar formation. Timely repression of the inflammatory response is critical for effective healing, and is followed by activation of myofibroblasts that secrete matrix proteins in the infarcted area. Members of the transforming growth factor β family are critically involved in suppression of inflammation and activation of a profibrotic programme. Translation of these concepts to the clinic requires an understanding of the pathophysiological complexity and heterogeneity of postinfarction remodelling in patients with myocardial infarction. Individuals with an overactive and prolonged postinfarction inflammatory response might exhibit left ventricular dilatation and systolic dysfunction and might benefit from targeted anti-IL-1 or anti-chemokine therapies, whereas patients with an exaggerated fibrogenic reaction can develop heart failure with preserved ejection fraction and might require inhibition of the Smad3 (mothers against decapentaplegic homolog 3) cascade. Biomarker-based approaches are needed to identify patients with distinct pathophysiologic responses and to rationally implement inflammation-modulating strategies.read more
Citations
More filters
Book
Coronary Microvascular Dysfunction
Paolo G. Camici,Filippo Crea +1 more
TL;DR: This review discusses the pathogenesis and management of coronary microvascular dysfunction and factors to consider in clinical management are the cause of the dysfunction and whether it is iatrogenic, whether obstructive coronary artery disease is present, and whether myocardial disease ispresent.
Journal ArticleDOI
The Biological Basis for Cardiac Repair After Myocardial Infarction: From Inflammation to Fibrosis
TL;DR: The renin-angiotensin-aldosterone system and members of the transforming growth factor-β family play an important role in activation of infarct myofibroblasts, and therapeutic modulation of the inflammatory and reparative response may hold promise for the prevention of postinfarction heart failure.
Journal ArticleDOI
Reactive Oxygen Species (ROS)-Based Nanomedicine.
Bowen Yang,Yu Chen,Jianlin Shi +2 more
TL;DR: In this article, the intrinsic biochemical properties of reactive oxygen species (ROS) underlie the mechanisms that regulate various physiological functions of living organisms, and they play an essential role in regulating various physiological function.
Journal ArticleDOI
Inflammation and the pathogenesis of atrial fibrillation
TL;DR: Understanding the complex pathophysiological processes and dynamic changes of AF-associated inflammation might help to identify specific anti-inflammatory strategies for the prevention of AF.
Journal ArticleDOI
From C-Reactive Protein to Interleukin-6 to Interleukin-1: Moving Upstream To Identify Novel Targets for Atheroprotection.
TL;DR: A phase IIb study conducted among diabetic patients at high vascular risk indicates that canakinumab, a human monoclonal antibody that targets IL-1β, markedly reduces plasma levels of IL-6, hsCRP, and fibrinogen with little change in atherogenic lipids.
References
More filters
Journal ArticleDOI
Relaxin Prevents Cardiac Fibroblast-Myofibroblast Transition via Notch-1-Mediated Inhibition of TGF-β/Smad3 Signaling
Chiara Sassoli,Flaminia Chellini,Alessandro Pini,Alessia Tani,Silvia Nistri,Daniele Nosi,Sandra Zecchi-Orlandini,Daniele Bani,Lucia Formigli +8 more
TL;DR: The results of the present study provide novel experimental evidence on the molecular mechanisms underlying the role of RLX in the field of cardiac fibrosis, and suggest that Notch signaling can down-regulate TGF-β1/Smad3-induced fibroblast-myofibroblast transition.
Journal ArticleDOI
Antibody against interleukin-6 receptor attenuates left ventricular remodelling after myocardial infarction in mice.
Miyuki Kobara,Kazuki Noda,Miho Kitamura,Akiharu Okamoto,Tatsuya Shiraishi,Hiroe Toba,Hiroaki Matsubara,Tetsuo Nakata +7 more
TL;DR: Administration of MR16-1 after MI suppressed myocardial inflammation, resulting in the amelioration of LV remodelling, and Neutralization of the IL-6 receptor is a potentially useful strategy for protecting hearts fromLV remodelling after MI.
Journal ArticleDOI
Induction and suppression of interferon-inducible protein 10 in reperfused myocardial infarcts may regulate angiogenesis.
Nikolaos G. Frangogiannis,Leonardo H. Mendoza,Mark Lewallen,Lloyd H. Michael,C. Wayne Smith,Mark L. Entman +5 more
TL;DR: Induction of angiostatic factors, such as IP‐10, in the first hours following injury may be important in inhibiting premature neovessel formation, until the appropriate supportive matrix is present, as well as allowing unopposed VEGF‐ and IL‐8‐mediated angiogenic activity.
Journal ArticleDOI
Origin, development, and differentiation of cardiac fibroblasts
TL;DR: In this article, a review of the role played by cardiac fibroblasts and myofibroblusters throughout development and periods of injury with the intent of emphasizing the duality of their nature is presented.
Journal ArticleDOI
Role of gp130-mediated signalling pathways in the heart and its impact on potential therapeutic aspects
P Fischer,D Hilfiker-Kleiner +1 more
TL;DR: The basic principles of gp130 signalling, which requires simultaneous activation of STAT and ERK pathways under the tight control of positive and negative intracellular signalling modulators to provide a balanced biological outcome, are summarized.
Related Papers (5)
The Biological Basis for Cardiac Repair After Myocardial Infarction: From Inflammation to Fibrosis
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
Paul M. Ridker,Brendan M. Everett,Tom Thuren,Jean G. MacFadyen,William Chang,Christie M. Ballantyne,Francisco H. Fonseca,Jose C. Nicolau,Wolfgang Koenig,Stefan D. Anker,John J.P. Kastelein,Jan H. Cornel,Prem Pais,Daniel Pella,Jacques Genest,Renata Cifkova,Alberto J. Lorenzatti,Tamás Forster,Zhanna Kobalava,Luminita Vida-Simiti,Marcus Flather,Hiroaki Shimokawa,Hisao Ogawa,Mikael Dellborg,Paulo Roberto Ferreira Rossi,Roland P.T. Troquay,Peter Libby,Robert J. Glynn +27 more